ReviewSubstance use & misuse2005
Pharmacotherapy of comorbid mood, anxiety, and substance use disorders.
Review in Substance use & misuse, 2005. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 16 papers.
What it found
Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.
The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.
The trial behind it
Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.
Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.
Who cites it
16 citing papers in PubMed.
- AI in Mental Health: Transforming Diagnosis and Management of Depression and Anxiety.Health science reports · 2026Article
- Depression and Its Phytopharmacotherapy-A Narrative Review.International journal of molecular sciences · 2023Review
- Comorbidities of Major Depressive Disorder and Bipolar Disorders in Patients with Substance Use Disorder in Iran Psychiatric Hospital: A Cross-sectional Study.Medical journal of the Islamic Republic of Iran · 2023Article
- Re-Purposing FDA-Approved Drugs for Opioid Use Disorder.Substance use & misuse · 2023Observational
- Was Hawan Designed to Fight Anxiety-Scientific Evidences?Journal of religion and health · 2020Review
- Network Analysis and Precision Rehabilitation for the Post-concussion Syndrome.Frontiers in neurology · 2019Review
- Behavioral effects of bidirectional modulators of brain monoamines reserpine and d-amphetamine in zebrafish.Brain research · 2013Article
- Integrated treatment of substance use and psychiatric disorders.Social work in public health · 2013Review
- The serotonin 2C receptor antagonist SB 242084 exhibits abuse-related effects typical of stimulants in squirrel monkeys.The Journal of pharmacology and experimental therapeutics · 2012Article
- Exploring the comorbidity of anxiety and substance use disorders.Current psychiatry reports · 2012Review
- Treatment of substance abusing patients with comorbid psychiatric disorders.Addictive behaviors · 2012Review
- Anxiety and alcohol use disorders: comorbidity and treatment considerations.Alcohol research : current reviews · 2012Article
- Repeated stimulation of CRF receptors in the BNST of rats selectively induces social but not panic-like anxiety.Neuropsychopharmacology : official publication of the American College of Neuropsychopharmacology · 2008Article
- Enhanced sensitivity to naltrexone-induced drinking suppression of fluid intake and sucrose consumption in maternally separated rats.Pharmacology, biochemistry, and behavior · 2007Article
- Treatment of co-occurring anxiety disorders and substance use disorders.Harvard review of psychiatryReview
- Neurobiological processes in adolescent addictive disorders.The American journal on addictionsReview
Corrections and comments
- Commented on by
Authors and funding
2 authors.
Funding
No grant is acknowledged in the PubMed record.
Abstract
Mood and anxiety disorders commonly co-occur with substance use disorders. Exploration of the neurobiology of substance use disorders and mood and anxiety disorders have found that the neural circuitry in mood, anxiety, and substance use disorders is clearly overlapping. These discoveries have encouraged the exploration of a number of pharmacotherapeutic agents in the treatment of co-occurring mood, anxiety, and substance use disorders. In this article, recent data on the pharmacotherapeutic treatment of mood and anxiety disorders in individuals with substance use disorders are reviewed. Some of the barriers to the use of pharmacotherapy in individuals with substance use disorders are discussed.
Indexed as
Identifiers
16282091What OpenQuestion holds
Registered trials
Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.